Tipiracil Hydrochloride; Trifluridine Patent Expiration
Tipiracil Hydrochloride; Trifluridine is Used for treating metastatic colorectal cancer in patients previously treated with specific chemotherapy combinations. It was first introduced by Taiho Oncology Inc
Tipiracil Hydrochloride; Trifluridine Patents
Given below is the list of patents protecting Tipiracil Hydrochloride; Trifluridine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lonsurf | US10456399 | Method for treating cancer patients with severe renal impairment | Feb 03, 2037 | Taiho Oncology |
| Lonsurf | US10960004 | Method for treating cancer patients with severe renal impairment | Feb 03, 2037 | Taiho Oncology |
| Lonsurf | US9943537 | Antitumor agent and antitumor effect enhancer | Sep 05, 2034 | Taiho Oncology |
| Lonsurf | US10457666 | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | Jun 17, 2034 | Taiho Oncology |
| Lonsurf | US9527833 | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | Jun 17, 2034 | Taiho Oncology |
| Lonsurf | USRE46284 | Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor | Sep 22, 2029 | Taiho Oncology |
| Lonsurf | US7799783 | Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor | Dec 16, 2026 | Taiho Oncology |
| Lonsurf | US6479500 | Agents for alleviating side effects |
Mar 16, 2020
(Expired) | Taiho Oncology |
| Lonsurf | US5744475 | Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same |
Mar 28, 2016
(Expired) | Taiho Oncology |
Tipiracil Hydrochloride; Trifluridine's Family Patents
Explore Our Curated Drug Screens
Tipiracil Hydrochloride; Trifluridine Generic API Manufacturers
Several generic applications have been filed for Tipiracil Hydrochloride; Trifluridine. The first generic version for Tipiracil Hydrochloride; Trifluridine was by Natco Pharma Ltd and was approved on Jun 13, 2023. And the latest generic version is by Msn Laboratories Private Ltd and was approved on Jan 8, 2025.
Given below is the list of companies who have filed for Tipiracil Hydrochloride; Trifluridine generic, along with the locations of their manufacturing plants worldwide.
1. MSN
Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Tipiracil Hydrochloride; Trifluridine. All of these versions come by the name TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6.14MG BASE; 15MG | tablet | Prescription | ORAL | AB | Jan 8, 2025 |
| EQ 8.19MG BASE; 20MG | tablet | Prescription | ORAL | AB | Jan 8, 2025 |
Manufacturing Plant Locations New
Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||
| United States |
| |||||||||||||||||||||
2. NATCO
Natco Pharma Ltd has filed for 2 different strengths of generic version for Tipiracil Hydrochloride; Trifluridine. All of these versions come by the name TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE. Given below are the details of the strengths of this generic introduced by Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6.14MG BASE; 15MG | tablet | Prescription | ORAL | AB | Jun 13, 2023 |
| EQ 8.19MG BASE; 20MG | tablet | Prescription | ORAL | AB | Jun 13, 2023 |
Manufacturing Plant Locations New
Natco's manufacturing plants are situated in 2 countries - United Kingdom, India. Given below are the details of these plant locations as well as the firm names of Natco as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Kingdom |
| |||||||||||||
| India |
| |||||||||||||